Page last updated: 2024-08-23

1-deoxynojirimycin and Lupus Erythematosus, Systemic

1-deoxynojirimycin has been researched along with Lupus Erythematosus, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butters, T; Deepak, S; Hall, CJ; Isenberg, DA; Jury, EC; Magee, AI; McDonald, G; Miguel, L1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and Lupus Erythematosus, Systemic

ArticleYear
Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:2

    Topics: 1-Deoxynojirimycin; Adult; Aged; Antigens, CD; B-Lymphocytes; CD4-Positive T-Lymphocytes; Female; Flow Cytometry; G(M1) Ganglioside; Gene Expression Regulation; Glycosphingolipids; Homeostasis; Humans; Lactosylceramides; Leukocytes, Mononuclear; Liver X Receptors; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Membrane Microdomains; Middle Aged; Orphan Nuclear Receptors; Signal Transduction; Time Factors; Trihexosylceramides

2014